AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Ventricular Assist Devices Market 2020-2024 | Evolving Opportunities with Abiomed Inc. and CorWave SA | Technavio

December 3, 2019
Global Ventricular Assist Devices Market 2020-2024 | Evolving Opportunities with Abiomed Inc. and CorWave SA | Technavio
Global Ventricular Assist Devices Market 2020-2024 | Evolving Opportunities with Abiomed Inc. and CorWave SA | Technavio

LONDON--(BUSINESS WIRE)--Dec 3, 2019--

Technavio has been monitoring the global ventricular assist devices market since 2015 and the market is poised to grow by USD 943.27 million during 2020-2024 at a CAGR of almost 12% during the forecast period. Request Free Sample Pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191203005457/en/

Technavio has announced its latest market research report titled global ventricular assist devices market 2020-2024. (Graphic: Business Wire)

Read the 145-page research report with TOC on “Ventricular Assist Devices Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Product (Left and right ventricular assist devices, and Bi-ventricular assist devices), and Segment Forecasts, 2020-2024”.

The market is driven by the increasing prevalence of heart failure. In addition, increase in technological advances is anticipated to further boost the growth of the ventricular assist devices market.

Patients who suffer from chronic cardiovascular diseases have a high risk of developing heart failure. Ischemic heart disease is found to be one of the most common causes of heart failure. Surgeons use implantable mechanical pumps such as ventricular assist devices in patients with heart failure or those with a weak heart muscle. In addition, the implantation of ventricular assist devices is also recommended for patients with congestive heart failure. Thus, the increasing prevalence of heart failure is expected to drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Ventricular Assist Devices Market Companies:

Abbott Laboratories

Abbott Laboratories is headquartered in the US and operates the business under various segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. The company offers a left ventricular assist device, HeartMate 3 LVAD.

Abiomed Inc.

Abiomed Inc. is headquartered in the US and offers products through its Unified business segment. The company offers Impella 2.5 and Impella RP to various end-user industries including hospitals, clinics, and ASCs.

Asahi Kasei Corp.

Asahi Kasei Corp. is headquartered in Japan and operates under various business segments, namely Material, Homes, and Health Care. The company offers an implantable left ventricular assist system, Evaheart LVAS.

Berlin Heart GmbH

Berlin Heart GmbH is headquartered in Germany and offers products through its Unified Business Segment. The company offers a mechanical paracorporeal ventricular assist device, EXCOR Adult to various end-user industries including hospitals, clinics, and ASCs.

CorWave SA

CorWave SA is headquartered in France and offers products through its Unified business segment. The company offers a next-generation left ventricular assist device, Neptune to various end-user industries including hospitals, clinics, and ASCs.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio’s SUBSCRIPTION platform

Ventricular Assist Devices Product Outlook (Revenue, USD Million, 2020-2024)

Ventricular Assist Devices Regional Outlook (Revenue, USD Million, 2020-2024)

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report

Related Reports on Health Careare:

Cardiovascular Therapeutics Market – Global Cardiovascular Therapeutics Market by geography (Asia, Europe, North America, and ROW) and product (antihypertensive drugs, hypolipidemic drugs, antithrombotic drugs, and other drugs).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191203005457/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:https://www.technavio.com

KEYWORD: UNITED STATES FRANCE JAPAN NORTH AMERICA ASIA PACIFIC EUROPE GERMANY

INDUSTRY KEYWORD: HEALTH SURGERY CARDIOLOGY MEDICAL DEVICES

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 12/03/2019 09:00 AM/DISC: 12/03/2019 09:01 AM

http://www.businesswire.com/news/home/20191203005457/en